TransCode Therapeutics Inc News - RNAZ

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Form 8-K - Current report

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the...

Form 8-K - Current report

TransCode Therapeutics, Inc. Announces $8 Million Private Placement

BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA Oncology...

Form 8-K - Current report

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split

BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

TransCode Therapeutics Open Letter to Shareholders

BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The Board and Management of TransCode Therapeutics (NASDAQ: RNAZ...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance

BOSTON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA oncology...

Form DEF 14A - Other definitive proxy statements

TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data

The clinical trial Safety Review Committee (SRC) approved opening of Cohort 2 after review of safety data from...

Form PRE 14A - Other preliminary proxy statements

MartinLutherKing 29 minutes ago

Non believers have left the spaceship 🚀🚀🚀

👍️0

MartinLutherKing 30 minutes ago

All Aboard who believes🚀🚀🚀🚀🚀🚀

👍️0

tapioca 43 minutes ago

Looks like it will land just under $9, if the pps holds here in mid 20’s. I’m tempted to buy more since I’m slightly red now, but I just don’t trust anything this company does, particularly with this r/s. I agree there could be a short attack if there isn’t huge news and volume attached to this split.

👍️0

MartinLutherKing 2 hours ago

You can’t keep the power of nobel prize cancer micro rna breakthrough short forever, She is going to blow to historical highs

👍️0

MartinLutherKing 2 hours ago

Big Buy pressure with cancer breakthrough with microscopic float

👍️0

MartinLutherKing 2 hours ago

Get in if you believe get out if you don’t Cancer world wide nobel prize breakthrough

👍️0

MartinLutherKing 2 hours ago

911 911 101 101 help help shorts in bed with mm’s big surprise coming to town

👍️0

Here Today 2 hours ago

Also and I do not remember exactly but this last Private Placement they just did for the $8 million I believe has a stipulation in it as to how long before the company can issue any further stocks. So they better have a legit plan in place to do right with the money or else all these RS's were for nothing in my opinion!!!!!

Seems more like eventually we may be seeing the "Snakes" slithering out of the weeds with all the "Be the first or Be Included in a Shareholders Class Action Lawsuit all over the place.....

👍️0

Here Today 2 hours ago

Although I would welcome that with open arms, it looks more like by end of day this will be at $.18 - $.20 range if not lower. What this piece of shit CEO doesn't understand is that there are scrupulous forces at work and once the RS is complete will only buy a short time before the Shorts will bury the share price again.

👍️0

MartinLutherKing 3 hours ago

RNAZ Going nuclear🚀🚀🚀🚀🚀🚀🚀🚀

👍️0

MartinLutherKing 3 hours ago

Don’t underestimate the power of nobel prize micro-Rna

👍️0

MartinLutherKing 3 hours ago

Cancer cure bots will unleash hell on the holy grail of cancer research

👍️0

MartinLutherKing 3 hours ago

2000$ Cancer Breakthrough Worldwide🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

👍️0

MartinLutherKing 8 hours ago

Should would could hit 1000$ a share with fda fast track 😂😂😂

👍️0

Here Today 8 hours ago

If you truly believed that they are doing this 33 for 1 reverse split and have good news pending right after, then they are even more criminal then first thought. This will be the 3rd reverse split in short timeframe.

👍️0

MartinLutherKing 8 hours ago

Clinical trial news results, FDA fast track status

👍️0

Here Today 8 hours ago

Where's the news????? Been multiple days saying the same thing. And what happens??? Nothing except After Hours Reverse Split News !!!!!

👍️0

MartinLutherKing 23 hours ago

The bots are in full swing with mm’s in bed with the shorts

👍️0

MartinLutherKing 23 hours ago

News is coming to town A/H Hold to the nuclear bots to all activate

👍️0

Tiger Money 23 hours ago

Agreed

👍️0

MartinLutherKing 23 hours ago

Mm’s And short signal panic with the bots 1 trades

👍️0

MartinLutherKing 23 hours ago

The bots have invaded, the bots have taken control

👍️0

Here Today 1 day ago

I find it interestingly strange that no further updates have been made on the Clinicals Trial site since October 15th and nothing from management or the board about it either. Normally they would provide an update as to how many have been recruited periodically, etc. But here it seems like company management is dead set on just getting this additional RS done. Sickening.

👍️0

tw0122 1 day ago

Yep 33 to 1 at .27 looks like shares might be slightly cheaper pre-split but you need to buy
33 to equal 1 and hope you hit a good price prior to split if you go that route. Market cap
going lower. Always easier to see what happens post split and less risky.

👍️0

Here Today 1 day ago

You, me and everyone else who has been buying and getting RS'd by these bastards!!! Need $5,000 a share to get even now. They will run this down to $.10 a share by tomorrow at this rate!

👍️0

Tiger Money 1 day ago

I'm debating as this thing always goes against me....

Tiger Money 1 day ago

Thanks!

👍️0

Here Today 1 day ago

Trading opens on Wednesday morning 12/04/24 with the new Cusip # and RS already completed I believe is what the PR I posted this morning from last week said.

👍️0

Tiger Money 1 day ago

When is the next reverse split? Thanks

👍️0

tw0122 1 day ago

Lower market cap lost .31 support see you at .21-.25 next

👍️0

tw0122 1 day ago

Market cap at 6m how low can she go..

👍️0

zeusgodmd 1 day ago

They are going to shake the short shares out

👍️0

Here Today 1 day ago

In connection with the reverse stock split, the Company's CUSIP number will change to 89357L402 as of 12:01 a.m. Eastern Standard Time on December 4, 2024.

https://ir.transcodetherapeutics.com/news-releases/news-release-details/transcode-therapeutics-announces-effective-date-1-33-reverse

👍️0

Here Today 1 day ago

Unfortunately they posted the reverse split with the new Cusip # to take effect December 4.

👍️0

MetaMonster 2 days ago

Maybe the dirty rat bastard scumbag motherfucker Tom Fitzgerald CEO piece of shit bastard has a plan

👍️0

zeusgodmd 3 days ago

I would say probably a smart rs the ceo is taking the low of this stock and keeping it above 5$. If the stock was to drop below 19 cents will still be above 5$ after rs

👍️0

zeusgodmd 3 days ago

You guys may see a holo run shares will be about 11$ 700000 out there and institutional investors can jump in above 5$. If price falls then reload I'm in on free shares. 4th will be the day

👍️0

MartinLutherKing 4 days ago

Nuclear bots about to activate with big news A\H

👍️0

TOM611 4 days ago

Maybe no RS since they got the $8 million private placement??

👍️0

Money hunt 4 days ago

News going to hit A/H dudes!!! Surfs up dudes!!!

👍️0

tw0122 4 days ago

Hopefully they announce something .. but if not can always ditch some more Stillhold some free flip shares. Must hold .33 if not .31 and .26 next on downside

👍️0

Money hunt 5 days ago

A private placement "certain institutional investors"were likely all ready to get in before the recent shareholders' meeting. They got reassurance, based on the shareholders' meeting outcome, that Transcode will not be delisted and that "minimum bid requirement" is going to be met by a reverse split if needed. Any good news might help with minimum bid - but, as Transcode's Board said, there is no assurance that such news would come or the same would help at all with a minimum bid requirement.

👍️0

MartinLutherKing 5 days ago

$3 News coming tomorrow morning brother stay tuned P/M

👍️0

MartinLutherKing 5 days ago

Pharma whales lurking waters for the kill brothers The nuclear bots are all about to activate and unleash the holy grail of cancer research

👍️0

MartinLutherKing 5 days ago

Happy thanksgiving y’all god bless RNAZ Micro Rna nobel prize revolution 🚀🚀🚀🚀

👍️0

MartinLutherKing 5 days ago

The world is about to wake up to the revolution of medicine breakthrough international nobel prize clinical trial

👍️0

MartinLutherKing 5 days ago

RNAZ🚀🚀 ELAB🚀🚀 Micro-Rna First of its class nobel prize clinical trials with FDA

👍️0

MartinLutherKing 5 days ago

Another micro-Rna nobel prize based clinical trials with FDA for obesity ELAB

👍️0

MartinLutherKing 5 days ago

ELAb micro Rna launch just reversed let’s see how it goes https://www.sciencedirect.com/science/article/pii/S2352320423001384

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

TransCode Therapeutics Inc (RNAZ)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

RNAZ News

Form 8-K - Current report

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

Form 8-K - Current report

TransCode Therapeutics, Inc. Announces $8 Million Private Placement

Form 8-K - Current report

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

TransCode Therapeutics Open Letter to Shareholders

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance

Form DEF 14A - Other definitive proxy statements

TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data

Form PRE 14A - Other preliminary proxy statements

RNAZ Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

TransCode Therapeutics Inc (RNAZ) News

TransCode Therapeutics Inc (RNAZ)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

RNAZ News

Form 8-K - Current report

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

Form 8-K - Current report

TransCode Therapeutics, Inc. Announces $8 Million Private Placement

Form 8-K - Current report

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

TransCode Therapeutics Open Letter to Shareholders

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance

Form DEF 14A - Other definitive proxy statements

TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data

Form PRE 14A - Other preliminary proxy statements

RNAZ Discussion

Your Recent History

Company

Business

Popular

Get The App